A major climate bill, a big win in Kansas … Could Democrats be on a roll?
a “new generation of leaders.” Hats off to New York Rep. Carolyn Maloney for getting weird about it though! She can’t really say it’s time for a “new generation of leaders,” as she’s locked in a member-on-member primary against a fellow senior committee chairman, Rep. Jerry Nadler, to determine which of them will serve a 175term. So, in a debate this week, when the candidates were asked whether Biden should run again, Maloney said: “I don’t believe he is running for reelection.
Before he cut a deal with Schumer on the Inflation Reduction Act, he was a candidate for beatification in Republicans’ eyes. He alone stood to thwart Democrats’ plans to turn American into an evil, nefariously Green socialist country like Denmark, the very pit of Hell. Since cutting the deal though, Republicansto be the worst sort of person, and truly cannot wait to take him out in 2024 . They’re also threatening to make him look like a sucker.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Dems' climate, energy, tax bill clears initial Senate hurdleThe Senate's nonpartisan rules arbiter has dealt a blow to Democrats’ plan for curbing drug prices.
Les mer »
Dems’ climate, energy, tax bill clears initial Senate hurdleDemocrats plan for the Senate to begin considering the bill Saturday, and the House will return next Friday for votes.
Les mer »
Dems' climate, energy, tax bill clears initial Senate hurdleA divided Senate has voted to start debating Democrats’ election-year economic bill
Les mer »
Dear Abby: After being bullied in school, should I confront classmates 35 years later?Bullying has long-lasting consequences, and that pain never really goes away.
Les mer »
12-Year-Old Archie Battersbee Dies After Being Removed From Life SupportArchie’s family lost a weeks-long court battle to continue life-saving treatment last week.
Les mer »
Long-lasting HIV prevention drug could be game changer — but who will pay?Injectable antiviral cabotegravir provides stronger protection than oral pill, but researchers fear it could be too expensive to make a difference for countries with the greatest disease burden.
Les mer »